BioPeptide WikiMitochondrial peptide evidence
Illustration of mitochondrial cristae and an evidence progression from laboratory research to regulatory review
Mitochondrial peptide evidence library

Trace the
evidence.

Explore mitochondrial-derived peptides, mitochondria-targeting compounds, human studies, clinical trials, safety questions, and regulatory status.

Explore compound files Open the evidence library
30 compound files 480 evidence reviews 3 featured editorial desks
The essential idea

Five claims.
Five different standards.

A peptide found in the body, a biomarker association, an animal result, a completed human trial, and FDA approval are not interchangeable forms of evidence.

Learn how we grade mitochondrial peptide evidence
AGPS
Compound index01

Identify the exact molecule before comparing claims.

Each file separates identity and aliases, mechanism, preclinical findings, human evidence, trial status, regulatory status, safety, and unknowns.

See all compound files
A disciplined evidence path

From molecule to supported conclusion.

Every claim is tied to the type of study that can actually support it.

  1. 01

    Identify the molecule

    Separate endogenous peptides, synthetic analogues, targeting peptides, and approved products.

  2. 02

    Locate the evidence level

    Distinguish cell and animal experiments from observational human studies and intervention trials.

  3. 03

    Check the human endpoint

    Ask whether a study measured a biomarker, a surrogate endpoint, function, symptoms, or clinical outcomes.

  4. 04

    Verify regulatory status

    Separate trial registration, advisory review, accelerated approval, and full approval for a defined indication.

Mitochondrial inner membrane and cristae evidence illustration
Conceptual illustration; evidence status must be verified in primary sources
Read the evidence ladder

Mechanism is not clinical proof.

A plausible mitochondrial target can justify research, but it cannot establish human benefit, long-term safety, or an approved indication on its own.

01
Biological identityConfirm whether the subject is endogenous, synthetic, or an analogue.
02
Study contextRecord the model, dose context, comparator, endpoint, and study limitations.
03
Regulatory boundaryState the exact indication and never generalize an approval beyond its label.
Read our evidence and corrections policy
Latest research02

Evidence separated by study type and status.

Read mechanism reviews, preclinical findings, human studies, clinical trials, safety analyses, and regulatory updates.

Open the research library
Browse by question

Find the subject behind the headline.

Product Identity0 guidesClinical Evidence0 guidesPreclinical Research0 guidesRegulatory Status0 guidesSafety and Evidence Limits0 guidesWiki Entry120 guidesAlias Resolution120 guidesResearch Timeline120 guides
Declared editorial responsibility

Collective desks, clearly identified.

These bylines identify editorial functions, not individual clinicians. Each desk has a defined scope and no invented personal credentials.

Meet the editorial desks
EREvidence Review DeskResearch Evidence EditorsPIProduct Identity DeskCatalog Identity EditorsRCRegulatory Context DeskRegulatory Research Editors
Start with clarity

Separate what is known from what is only proposed.

Compare evidence filesReport a correction